Nonfermenting Gram-Negative Bacilli Infections in a Tertiary Care Hospital in Kolar, KarnatakaSource of Support: Nil
AIM: Nonfermenting gram-negative bacilli (NFGNB), which are saprophytic in nature, have emerged as important healthcare-associated pathogens. They exhibit resistance not only to beta lactam and the other groups of antibiotics, but also to carbapenems. This study was undertaken to identify the nonfermenters isolated from various clinical samples, to assess their clinical significance, to know the type of healthcare-associated infections they caused, and to know their anti-microbial sensitivity pattern.
Materials and Methods: The nonfermenters were identified using a standard protocol that included tests for motility, oxidase production, oxidation-fermentation test for various sugars, gelatin liquefaction, and growth on 10% lactose agar. The clinical significance was assessed by using various criteria and susceptibility testing was performed with the help of the Kirby-Bauer disc diffusion method.
Results: A total of 193 NFGNB were isolated from 189 clinical specimens. Pseudomonas aeruginosa was the most common nonfermenter, accounting for 53.8%, followed by Acinetobacter baumannii (22.2%), and Pseudomonas fluorescens (10.8%). Other significant NFGNB isolated were: Sphingobacterium species (5.2%), Acinetobacter lwoffii (3.1%), and Stenotrophomonas maltophilia (2.6%). P. aeruginosa showed good sensitivity to imipenem (94%), cefoperazone (70%), amikacin (69%), and ticarcillin (63%). A. baumannii showed 100% sensitivity to imipenem and 70% sensitivity to piperacillin.
Conclusion: P. aeruginosa and A. baumannii were the common NFGNB isolated in our study from patients of, urinary tract infection, bacteremia, surgical site infections, and ventilator associated pneumonia. P. aeruginosa showed good sensitivity to imipenem, amikacin, and cefoperazone while A. baumannii showed good sensitivity to imipenem and piperacillin.
KeywordsAcinetobacter baumannii - imipenem - clinical significance - nosocomial pathogens - Pseudomonas aeruginosa
29 January 2020 (online)
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
- 1 Winn W Jr, Allen S, Janda W, Koneman E, Procop G, Schreckenberger P, et al., editors. Nonfermenting Gram negative bacilli. In: Koneman's Color Atlas and textbook of Diagnostic Microbiology, 6 th ed. USA: Lippincott Williams and Wilkins Company; 2006. p. 305-91.
- 2 Steinberg JP, Rio DC. Other Gram negative and Gram variable bacilli. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious diseases, 6 th ed. vol. 2. Philadelphia, USA: Elsevier Publication; 2005. p. 2751-68.
- 3 Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: Geographic patterns, Epidemiological features, and trends in the SENTRY antimicrobial surveillance program (1997-1999). Clin Infect Dis 2001;32:104-13.
- 4 Rubin SJ, Granato PA, Wasilauskas BL. Glucose nonfermenting Gram negative bacteria. In : Lennette EH, Balows A, Hausler WJ Jr, Shadomy HJ, editors. Manual of Clinical Microbiology, 4 th ed. Washington, D.C: American Society for Microbiology; 1985. p. 330-49.
- 5 Meherwal SK, Taneja N, Sharma SK, Sharma M. Complicated nosocomial UTI caused by nonfermenters. Indian J Urol 2002;18:123-8.
- 6 Hill EB, Henry DA, Speert DP. Pseudomonas. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, editors. Manual of Clinical Microbiology, vol. 1, 9 th ed. Washington, D.C: American Society for Microbiology; 2007. p. 734-48.
- 7 Quinn JP. Clinical problems posed by multiresistant nonfermenting gram negative pathogens. Clin Infect Dis 1998;27: S117-24.
- 8 National Committee for Clinical Laboratory Standards. Performance Standards for antimicrobial susceptibility testing: Eleventh informational supplement. NCCLS document M100-S11, Vol. 21 No. 1. NCCLS, Wayne, PA: 2001.
- 9 Troillet N, Samore MH, Carmeli Y. Imipenem-Resistant Pseudomonas aeruginosa: Risk factors and Antibiotic susceptibility patterns. Clin Infect Dis 1997;25:1094-8.
- 10 Yashodara P, Shyamala S. Identification and characterization of nonfermenters from clinical specimens. Indian J Med Microbiol 1997;15:195-7.
- 11 Mishra B, Bhujwala RA, Shriniwas. Nonfermenters in human infections. Indian J Med Res 1986;83:561-6.
- 12 Marinella MA. Cellulitis and sepsis due to Sphingobacterium. JAMA 2002;288:1985.
- 13 Prashanth K, Badrinath S. In vitro susceptibility pattern of Acinetobacter species to commonly used cephalosporins, quinolones and aminoglycosides. Indian J Med Microbiol 2004;22:97-103.
- 14 Veenakumari HB, Nagarathna S, Chandramuki A. Antimicrobial resistance pattern among aerobic Gram negative bacilli of lower respiratory tract specimens of intensive care unit patients in a neurocentre. Indian J Chest Dis Allied Sci 2007;49:19-22.
- 15 Taneja N, Maharwal S, Sharma M. Imipenem resistance in nonfermenters causing nosocomial urinary tract infections. Indian J Med Sci 2003;57:294-9.
- 16 Sinha M, Srinivasa H, Macaden R. Antibiotic resistance profile and extended spectrum beta- lactamase (ESBL) production in Acinetobacter species. Indian J Med Res 2007;126:63-7.